170 related articles for article (PubMed ID: 34524161)
41. Polycystic ovary syndrome in adolescents.
Rothenberg SS; Beverley R; Barnard E; Baradaran-Shoraka M; Sanfilippo JS
Best Pract Res Clin Obstet Gynaecol; 2018 Apr; 48():103-114. PubMed ID: 28919160
[TBL] [Abstract][Full Text] [Related]
42. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Misso ML; Boyle JA; Garad RM; McAllister V; Downes L; Gibson M; Hart RJ; Rombauts L; Moran L; Dokras A; Laven J; Piltonen T; Rodgers RJ; Thondan M; Costello MF; Norman RJ;
Med J Aust; 2018 Oct; 209(S7):S3-S8. PubMed ID: 30453865
[TBL] [Abstract][Full Text] [Related]
43. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
Spritzer PM; Motta AB
Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
[TBL] [Abstract][Full Text] [Related]
44. Polycystic ovary syndrome.
Baldwin CY; Witchel SF
Pediatr Ann; 2006 Dec; 35(12):888-96. PubMed ID: 17236436
[TBL] [Abstract][Full Text] [Related]
45. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.
Teede H; Deeks A; Moran L
BMC Med; 2010 Jun; 8():41. PubMed ID: 20591140
[TBL] [Abstract][Full Text] [Related]
46. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
47. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
48. Polycystic ovary syndrome in adolescents: (women's health series).
Horn M; Geraci SA
South Med J; 2013 Oct; 106(10):570-6. PubMed ID: 24096951
[TBL] [Abstract][Full Text] [Related]
49. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
50. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
51. Polycystic Ovary Syndrome: Common Questions and Answers.
Williams T; Moore JB; Regehr J
Am Fam Physician; 2023 Mar; 107(3):264-272. PubMed ID: 36920819
[TBL] [Abstract][Full Text] [Related]
52. Polycystic ovary syndrome in adolescents.
Dabadghao P
Best Pract Res Clin Endocrinol Metab; 2019 Jun; 33(3):101272. PubMed ID: 31027973
[TBL] [Abstract][Full Text] [Related]
53. Polycystic ovary syndrome and female reproduction.
Elghblawi E
Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
[TBL] [Abstract][Full Text] [Related]
54. Clinical Implications of Polycystic Ovary Syndrome in Adolescents.
Hachey LM; Kroger-Jarvis M; Pavlik-Maus T; Leach R
Nurs Womens Health; 2020 Apr; 24(2):115-126. PubMed ID: 32273076
[TBL] [Abstract][Full Text] [Related]
55. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Fertil Steril; 2004 Jan; 81(1):19-25. PubMed ID: 14711538
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescents.
Trent M; Gordon CM
Pediatrics; 2020 May; 145(Suppl 2):S210-S218. PubMed ID: 32358213
[TBL] [Abstract][Full Text] [Related]
57. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis and treatment of polycystic ovarian syndrome in adolescents.
Nicandri KF; Hoeger K
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):497-504. PubMed ID: 23076041
[TBL] [Abstract][Full Text] [Related]
59. New perspectives on the definition and management of polycystic ovary syndrome.
Pasquali R; Gambineri A
J Endocrinol Invest; 2018 Oct; 41(10):1123-1135. PubMed ID: 29363047
[TBL] [Abstract][Full Text] [Related]
60. [Polycystic ovary syndrome].
Dewailly D
J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
